Artixio

Global Market Access Services

Your Partner for Global Market Access for Biopharmaceutical Therapies

Optimizing Time-to-Market for Biopharmaceuticals

Enabling patients’ access to therapies requires authorization from health authorities and payers’ acceptance of pricing based on therapy’s benefits and advantages over existing options. The pricing is driven by insights from key opinion leaders, prescribers’ understanding of the therapy, payers’ policies and regulatory framework on certain disease areas in the country.
The key benefits and advantages over existing treatments are part of drug development planning and therefore, it can be stated that Market Access is a key consideration right from the early stage of drug development.
Artixio’s team brings wealth of experience across complex therapeutic areas and global markets to help you address key questions for your market access strategy.

Pricing

  • Price comparator with existing therapies under applicable treatment setups to assess ‘effective cost of treatment’ through the lifecycle of treatment
  • Targeting expected indication and therapy
  • Existing therapeutic modalities and line of therapy
  • KOL opinion on new therapy’s advantages and benefits over current options
  • Risks based on side effects
  • Scientific data supporting product’s advantages

Reimbursement

  • Reimbursement policies in the country
  • Timeline and process for reimbursement approvals
  • Identification of primary markets for product launch based in reimbursement scenario

Market Overview

Market size

Market Landscape

Market research / KOL Analysis

Commercial Team Alignment

Target patients’ profiles:

Market access strategy:

Stakeholders Mapping & Networking

Internal stakeholders’ collaboration

External stakeholders:

HEOR Study

Study preparation:

Study report and publication

Local Expertise, Delivered Globally with Artixio

FAQs

What are key components of global Market Access Services?

The key components of Market Access include market research, market sizing (epidemiology, treatment algorithm, real world evidence assessment, key opinion leader analysis (KOL), target patient profile, reference product identification, pricing proposal, commercial team engagement, internal and external stakeholder engagement (prescribers, regulatory authorities, key opinion leaders etc), health economic outcome research (HEOR) and reporting.

Artixio has highly experienced medical, market research, regulatory and commercial experts with experienced across therapeutic areas, product categories (new chemical entities, biologics etc). Our specialists have successfully enrolled new therapies leveraging real world evidence in global and local markets, engaging key stakeholders in medical, scientific and regulatory communities and through data backed benchmarking against approved therapies for ensuring access to innovative biopharmaceuticals and commercial success of manufacturers.

Global biopharmaceutical companies often lack understanding of pricing and reimbursement regulations in new countries, lack access to key epidemiological and market data for market sizing and pricing analysis. Regional market access also requires sound knowledge and practical insights in preparing solid pricing proposals and application for reimbursement approvals; that in turn requires experience in successfully navigating local regulations and authorities.

Artixio’s central regulatory intelligence platform, Dvarka, has comprehensive intelligence on regulations for market access, pricing and reimbursement for key markets worldwide. Further, our regional commercial and regulatory experts keep track of new regulations, changes, guidelines, notifications and network based insights from health authorities, trade / industry associations and professional networks.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Regulatory
Services Across Multiple Industries

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Expert Regulatory Services To Streamline Compliance

Regulatory Intelligence & Strategy
Medical & Technical Writing
Publishing & Submission
Product Registration
Investigation New Drug Application (IND)
New Drug Application (NDA)
Post Approval Lifecycle Maintenance
Artwork and Label Review
Ad Promo Review

Regulatory Services Across Multiple Countries

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

European

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025